Today: 9 April 2026
Micron stock in focus: $1.8 billion Taiwan fab deal adds DRAM capacity as MU heads into a holiday break
17 January 2026
2 mins read

Micron stock in focus: $1.8 billion Taiwan fab deal adds DRAM capacity as MU heads into a holiday break

New York, Jan 17, 2026, 07:26 EST — Market closed.

  • Micron announced it has signed an exclusive letter of intent to acquire Powerchip’s P5 fab in Taiwan, paying $1.8 billion in cash.
  • Micron shares jumped 7.8% on Friday, closing at a record high following a director’s disclosure of a $7.8 million stock buy.
  • When U.S. markets open Tuesday after the holiday, traders will watch closely for the deal’s timing and any additional filings.

Micron Technology, Inc. announced Saturday it has signed an exclusive letter of intent to buy Powerchip Semiconductor Manufacturing Corp’s P5 fab in Tongluo, Taiwan. The $1.8 billion all-cash deal is designed to boost its memory production capacity. https://investors.micron.com/news-releases…

Investors have been pushing memory-chip stocks higher, betting that demand for DRAM—a key memory in servers, PCs, and phones—will remain strong as data centers ramp up capacity to handle AI workloads.

Micron’s rally will face a fresh test once trading picks back up. U.S. markets remain closed Monday for Martin Luther King Jr. Day, reopening on Tuesday. https://www.nasdaqtrader.com/trader.aspx?i…

Micron shares ended Friday’s session at $362.75, gaining $26.12, or roughly 7.8%, on the Nasdaq. The stock reached an intraday peak of $365.59.

Micron pointed out that the Tongluo site houses a 300mm cleanroom spanning roughly 300,000 square feet, a setup that could speed up capacity expansion compared to starting fresh. Executive vice president Manish Bhatia noted the acquisition would enable Micron to “better serve our customers in a market where demand continues to outpace supply.”

The company said the letter of intent also seeks to build a long-term partnership with Powerchip for post-wafer assembly processing — the packaging stages that convert wafers into finished chips — and to back Powerchip’s legacy DRAM business. Micron expects the deal to close by the second quarter of 2026, pending definitive agreements and regulatory approval, with significant DRAM wafer production from the site starting in the latter half of 2027.

Micron director Teyin M. Liu revealed in a Form 4 filing on Thursday that they bought 23,200 shares between Jan. 13 and 14, with the weighted average price hovering around $336 to $337. https://investors.micron.com/node/49946/ht…

The stock was already tracking the broader chip sector. Investing.com noted that memory stocks gained after Taiwan Semiconductor Manufacturing Co posted strong results and raised spending forecasts. Mizuho’s Jordan Klein highlighted solid demand for Micron shares following the insider buying announcement. https://www.investing.com/news/stock-marke…

Micron got the ball rolling Friday on its massive $100 billion megafab campus in central New York. CEO Sanjay Mehrotra addressed the crowd, saying, “On the fields today there is snow and soil,” asking them to envision the project as it comes to life. https://www.wrvo.org/2026-01-16/micron-bre…

That said, the Taiwan deal isn’t sealed yet. A letter of intent can unravel over final terms, and the plan hinges on regulatory approval plus a multiyear buildup before it boosts output significantly. Micron remains vulnerable to typical memory market risks: a drop in demand or a quick shift to oversupply that could weigh on chip prices.

Investors will be keeping an eye on Micron once markets reopen Tuesday, looking to see if the company sticks to the letter of intent or files a definitive agreement detailing timing, conditions, and how the deal fits into its overall spending strategy.

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
MARA stock pops 6.6% as bitcoin steadies near $95,000 — what to watch next week
Previous Story

MARA stock pops 6.6% as bitcoin steadies near $95,000 — what to watch next week

Federal Bank share price jumps on Q3 beat — what to watch when India markets reopen
Next Story

Federal Bank share price jumps on Q3 beat — what to watch when India markets reopen

Go toTop